Scholarlink

Purpose <p>To evaluate the current state of MRI-based radiomics for predicting clinically significant prostate cancer (csPCa) in PI-RADS 3 lesions and assess the quality of these radiomic studies via a systematic review of the published literature.</p> Methods <p>We conducted a literature search in PubMed, EMBASE, and SCOPUS databases from January 2017 to September 2024, using search terms containing variations of PI-RADS-3 and radiomics in abstract and titles. We collected details from the radiomic workflow for each study, including statistical performance of the radiomics models (area under the curve (AUC)). We calculated the pooled AUC across the studies and a radiomics quality score (RQS) to evaluate the quality of radiomics methodology.</p> Results <p>Of 52 articles retrieved, 14 met the selection criteria. Of these, 12 studies employed 3T MRI scanners, 8 studies T2WI, DWI, ADC images for feature extraction, and 13 studies performed manual segmentation. All but two studies used the <i>PyRadiomics</i> platform as their feature extraction tool. The most commonly used radiomic selection methods were Least Absolute Shrinkage and Selection Operator (LASSO). The total number of features extracted ranged between 107 and 2553. The median number of radiomics features selected for use in models was 10. Nine studies (9/14) explored clinical variables in their radiomics models, with the most common being age and PSA. For building the final model, Logistic Regression, and Univariate and Multivariate modeling methods were featured across eight studies (8/14). Overall performance of the models by pooled AUC was 0.823 (95% CI, 0.72, 0.92). The mean RQS score was 15/36 (range 13–19).</p> Conclusion <p>MRI-based radiomic models have potential in predicting csPCa in PI-RADS-3 lesions. However, using RQS as a guide, we determined there is a clear need to improve the methodological quality of existing and future studies by focusing on extensive validation and open publishing of data for reproducibility.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Predicting clinically significant prostate cancer in PI-RADS 3 lesions using MRI-based radiomics: a literature review of methodological variations and performance

  • 期刊论文

  • 发表日期：

    2025年4月2日

查看全文
  • Alejandro Serrano,
  • Christopher Louviere,
  • Anmol Singh,
  • Savas Ozdemir,
  • Mauricio Hernandez,
  • K. C. Balaji,
  • Dheeraj R. Gopireddy,
  • Kazim Z. Gumus

摘要

Purpose

To evaluate the current state of MRI-based radiomics for predicting clinically significant prostate cancer (csPCa) in PI-RADS 3 lesions and assess the quality of these radiomic studies via a systematic review of the published literature.

Methods

We conducted a literature search in PubMed, EMBASE, and SCOPUS databases from January 2017 to September 2024, using search terms containing variations of PI-RADS-3 and radiomics in abstract and titles. We collected details from the radiomic workflow for each study, including statistical performance of the radiomics models (area under the curve (AUC)). We calculated the pooled AUC across the studies and a radiomics quality score (RQS) to evaluate the quality of radiomics methodology.

Results

Of 52 articles retrieved, 14 met the selection criteria. Of these, 12 studies employed 3T MRI scanners, 8 studies T2WI, DWI, ADC images for feature extraction, and 13 studies performed manual segmentation. All but two studies used the PyRadiomics platform as their feature extraction tool. The most commonly used radiomic selection methods were Least Absolute Shrinkage and Selection Operator (LASSO). The total number of features extracted ranged between 107 and 2553. The median number of radiomics features selected for use in models was 10. Nine studies (9/14) explored clinical variables in their radiomics models, with the most common being age and PSA. For building the final model, Logistic Regression, and Univariate and Multivariate modeling methods were featured across eight studies (8/14). Overall performance of the models by pooled AUC was 0.823 (95% CI, 0.72, 0.92). The mean RQS score was 15/36 (range 13–19).

Conclusion

MRI-based radiomic models have potential in predicting csPCa in PI-RADS-3 lesions. However, using RQS as a guide, we determined there is a clear need to improve the methodological quality of existing and future studies by focusing on extensive validation and open publishing of data for reproducibility.

Graphical Abstract